
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Zika-HX Antigen
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Coordination Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Partnership
CPI Partners with Excivion to Optimise and Scale up Production of Safe and Effective Zika Vaccine
Details : Excivion has partnered with CPI to draw upon the company’s extensive experience in the optimisation and scale-up of biologics manufacturing processes to optimise the manufacture of their novel Zika vaccine antigen candidate, Zika-HX.
Product Name : Zika vaccine
Product Type : Vaccine
Upfront Cash : Undisclosed
July 13, 2020
Lead Product(s) : Zika-HX Antigen
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Coordination Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Partnership
